NO136410B - - Google Patents
Download PDFInfo
- Publication number
- NO136410B NO136410B NO799/73A NO79973A NO136410B NO 136410 B NO136410 B NO 136410B NO 799/73 A NO799/73 A NO 799/73A NO 79973 A NO79973 A NO 79973A NO 136410 B NO136410 B NO 136410B
- Authority
- NO
- Norway
- Prior art keywords
- methyl
- acid
- solution
- pyrazole
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- WSMQKESQZFQMFW-UHFFFAOYSA-N 5-methyl-pyrazole-3-carboxylic acid Chemical compound CC1=CC(C(O)=O)=NN1 WSMQKESQZFQMFW-UHFFFAOYSA-N 0.000 claims description 2
- 125000005036 alkoxyphenyl group Chemical group 0.000 claims description 2
- 239000003472 antidiabetic agent Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 150000003217 pyrazoles Chemical class 0.000 claims description 2
- 230000003178 anti-diabetic effect Effects 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 29
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 238000009835 boiling Methods 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- -1 alkyl esters Chemical class 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- JTAQEQNGUWRUDD-UHFFFAOYSA-N 5-methyl-n-(2-methyl-4,4-diphenyl-2,3-dihydropyrrol-5-yl)-1h-pyrazole-3-carboxamide Chemical compound N=1C(C)CC(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=1NC(=O)C1=CC(C)=NN1 JTAQEQNGUWRUDD-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- PRNAGQSGLUKHRO-UHFFFAOYSA-N 2,7-dimethyldipyrazolo[1,3-b:1',3'-e]pyrazine-4,9-dione Chemical compound O=C1C2=CC(C)=NN2C(=O)C2=CC(C)=NN21 PRNAGQSGLUKHRO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- KOPFEFZSAMLEHK-UHFFFAOYSA-N 1h-pyrazole-5-carboxylic acid Chemical compound OC(=O)C=1C=CNN=1 KOPFEFZSAMLEHK-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- BOTXQJAHRCGJEG-UHFFFAOYSA-N ethyl 5-methyl-1h-pyrazole-3-carboxylate Chemical compound CCOC(=O)C=1C=C(C)NN=1 BOTXQJAHRCGJEG-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- UYVKMNROFWNHHB-UHFFFAOYSA-N 2,2-bis(4-methoxyphenyl)acetonitrile Chemical compound C1=CC(OC)=CC=C1C(C#N)C1=CC=C(OC)C=C1 UYVKMNROFWNHHB-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- OUQQTGSMRRDSGS-UHFFFAOYSA-N 4,4-bis(4-methoxyphenyl)-2-methyl-2,3-dihydropyrrol-5-amine Chemical compound C1=CC(OC)=CC=C1C1(C=2C=CC(OC)=CC=2)C(N)=NC(C)C1 OUQQTGSMRRDSGS-UHFFFAOYSA-N 0.000 description 1
- 244000171897 Acacia nilotica subsp nilotica Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- KUAHLMKJIJSFNK-UHFFFAOYSA-N n-(2,2-dimethyl-4,4-diphenyl-3h-pyrrol-5-yl)-5-methyl-1h-pyrazole-3-carboxamide Chemical compound N1C(C)=CC(C(=O)NC=2C(CC(C)(C)N=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 KUAHLMKJIJSFNK-UHFFFAOYSA-N 0.000 description 1
- ZXVVULPVLPDJFZ-UHFFFAOYSA-N n-(4,4-diphenyl-2,3-dihydropyrrol-5-yl)-5-methyl-1h-pyrazole-3-carboxamide Chemical compound N1N=C(C)C=C1C(=O)NC1=NCCC1(C=1C=CC=CC=1)C1=CC=CC=C1 ZXVVULPVLPDJFZ-UHFFFAOYSA-N 0.000 description 1
- PXJHLQHKVKFKKN-UHFFFAOYSA-N n-[4,4-bis(4-methylphenyl)-2,3-dihydropyrrol-5-yl]-5-methyl-1h-pyrazole-3-carboxamide Chemical compound N1N=C(C)C=C1C(=O)NC1=NCCC1(C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 PXJHLQHKVKFKKN-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH276972A CH564011A5 (fr) | 1972-02-28 | 1972-02-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO136410B true NO136410B (fr) | 1977-05-23 |
| NO136410C NO136410C (no) | 1977-08-31 |
Family
ID=4241193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO799/73A NO136410C (no) | 1972-02-28 | 1973-02-27 | Analogifremgangsm}te til fremstilling av antidiabetisk virksomme 3-metyl-pyrazol-5-karboksamider. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US3875182A (fr) |
| JP (1) | JPS5544751B2 (fr) |
| AR (1) | AR200576A1 (fr) |
| AT (1) | AT318605B (fr) |
| AU (1) | AU468321B2 (fr) |
| BE (1) | BE795988A (fr) |
| CA (1) | CA991644A (fr) |
| CH (1) | CH564011A5 (fr) |
| DE (1) | DE2307301A1 (fr) |
| DK (1) | DK129657B (fr) |
| ES (1) | ES412086A1 (fr) |
| FR (1) | FR2181774B1 (fr) |
| GB (1) | GB1373333A (fr) |
| HU (1) | HU164260B (fr) |
| IE (1) | IE37293B1 (fr) |
| IL (1) | IL41309A (fr) |
| NL (1) | NL7301463A (fr) |
| NO (1) | NO136410C (fr) |
| PH (1) | PH9895A (fr) |
| SE (1) | SE410315B (fr) |
| ZA (1) | ZA73149B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2522688A1 (de) * | 1975-05-22 | 1976-12-09 | Boehringer Mannheim Gmbh | 3-nitropyrazol-derivate und verfahren zu deren herstellung |
| JPS6425763A (en) | 1987-04-24 | 1989-01-27 | Mitsubishi Chem Ind | Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient |
| US4861777A (en) * | 1987-09-11 | 1989-08-29 | Mitsubishi Kasei Corporation | Pyrazole derivative and insecticidal and miticidal composition containing the derivative as active ingredient |
| JP2751309B2 (ja) * | 1988-02-16 | 1998-05-18 | 三菱化学株式会社 | ピラゾール類およびこれを有効成分とする殺虫、殺ダニ、殺菌剤 |
| CN104291510A (zh) * | 2014-09-15 | 2015-01-21 | 北京理工大学 | 一种llm-105生产工艺中甲氧化废水废液的处理方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1539306A (fr) * | 1966-09-27 | 1968-09-13 | Carter Wallace | Amides de l'acide 3(5)-méthyl-5(3)-pyrazole-carboxylique |
-
1972
- 1972-02-28 CH CH276972A patent/CH564011A5/xx not_active IP Right Cessation
-
1973
- 1973-01-09 ZA ZA730149A patent/ZA73149B/xx unknown
- 1973-01-11 AU AU51013/73A patent/AU468321B2/en not_active Expired
- 1973-01-17 IL IL41309A patent/IL41309A/en unknown
- 1973-01-23 AR AR246246A patent/AR200576A1/es active
- 1973-02-01 NL NL7301463A patent/NL7301463A/xx not_active Application Discontinuation
- 1973-02-14 DE DE19732307301 patent/DE2307301A1/de not_active Ceased
- 1973-02-16 PH PH14351*A patent/PH9895A/en unknown
- 1973-02-16 DK DK83473AA patent/DK129657B/da unknown
- 1973-02-19 IE IE253/73A patent/IE37293B1/xx unknown
- 1973-02-22 JP JP2076673A patent/JPS5544751B2/ja not_active Expired
- 1973-02-23 US US335396A patent/US3875182A/en not_active Expired - Lifetime
- 1973-02-26 SE SE7302660A patent/SE410315B/xx unknown
- 1973-02-26 CA CA164,577A patent/CA991644A/en not_active Expired
- 1973-02-27 AT AT172573A patent/AT318605B/de not_active IP Right Cessation
- 1973-02-27 ES ES412086A patent/ES412086A1/es not_active Expired
- 1973-02-27 NO NO799/73A patent/NO136410C/no unknown
- 1973-02-27 HU HUHO1547A patent/HU164260B/hu unknown
- 1973-02-27 GB GB951973A patent/GB1373333A/en not_active Expired
- 1973-02-27 BE BE128119A patent/BE795988A/fr unknown
- 1973-02-28 FR FR7307083A patent/FR2181774B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU468321B2 (en) | 1976-01-08 |
| AR200576A1 (es) | 1974-11-22 |
| NL7301463A (fr) | 1973-08-30 |
| IL41309A0 (en) | 1973-03-30 |
| IE37293B1 (en) | 1977-06-22 |
| AT318605B (de) | 1974-11-11 |
| JPS5544751B2 (fr) | 1980-11-13 |
| BE795988A (fr) | 1973-08-27 |
| FR2181774A1 (fr) | 1973-12-07 |
| JPS4897873A (fr) | 1973-12-13 |
| GB1373333A (en) | 1974-11-13 |
| DE2307301A1 (de) | 1973-09-06 |
| ES412086A1 (es) | 1976-01-01 |
| SE410315B (sv) | 1979-10-08 |
| AU5101373A (en) | 1974-07-11 |
| FR2181774B1 (fr) | 1975-12-26 |
| NO136410C (no) | 1977-08-31 |
| HU164260B (fr) | 1974-01-28 |
| IE37293L (en) | 1973-08-28 |
| DK129657B (da) | 1974-11-04 |
| CH564011A5 (fr) | 1975-07-15 |
| IL41309A (en) | 1976-01-30 |
| CA991644A (en) | 1976-06-22 |
| ZA73149B (en) | 1973-10-31 |
| PH9895A (en) | 1976-06-08 |
| US3875182A (en) | 1975-04-01 |
| DK129657C (fr) | 1975-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2647853C2 (ru) | Способы получения определенных 2-(пиридин-3-ил)тиазолов | |
| KR880002298B1 (ko) | 술포네이트 유도체의 제조법 | |
| US4110337A (en) | Triazolobenzodiazepines | |
| MX2012005942A (es) | Procedimiento para la preparacion de {4,6-diamino-2-[1-(2-fluorobe ncil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}carbamato de metilo y su purificacion para el uso como principio activo farmaceutico. | |
| US2883384A (en) | Production of reserpine and analogs thereof | |
| NO173938B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido-pyridazinon-eddiksyrer | |
| NO173059B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive hydantoin-derivater | |
| CA1103245A (fr) | Procede de production de nouveaux derives de l'oxadiazolopyrimidine | |
| NO752493L (fr) | ||
| NO136410B (fr) | ||
| NO146775B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive racemiske eller optisk aktive kondenserte pyrimidinderivater | |
| McKillip et al. | Aminimides. I. A general synthesis of aminimides from acyl hydrazides and their pyrolysis | |
| NO166712B (no) | Fremgangsmaate ved fremstilling av pyrrolidonderivater. | |
| JPH0250110B2 (fr) | ||
| NO852308L (no) | Fremgangsmaate ved fremstilling av eburnanderivater | |
| US2906757A (en) | Their preparation | |
| NO814468L (no) | Tiazolinderivater, fremgangsmaate til deres fremstilling, deres anvendelse samt farmasoeytiske preparater paa basis av disse forbindelser | |
| US4005100A (en) | Pyrazole-5-carboxamides | |
| US3510495A (en) | Novel substituted 1-amino-2-pyrrolidinones | |
| US3277092A (en) | 5, 6-substituted dihydro-5-fluoropyrimidines | |
| US3442953A (en) | Novel 7-oxo-7-desacetylaminocolchicine compounds | |
| US3438976A (en) | 1-sulfonyl-3-nortropanyl-urea derivatives | |
| US2492373A (en) | Imidazolone preparation | |
| SU922108A1 (ru) | Способ получени производных 6-метил-8 @ -гидразинометилэрголина или их солей | |
| RU2798463C1 (ru) | 7-Бензил-9-бензоил-3-(4-бромфенил)-8-фенил-1,4-диокса-2,7-диазаспиро[4.4]нон-2,8-диен-6-он, обладающий противомикробной активностью |